Certified by Founder
Lodge
SolasCure
start up
United Kingdom
- Cambridge
- 28/03/2023
- Series B
- $13,422,000
SolasCure leverages biomimicry and evidence-based medicine to develop fit for purpose, efficacious wound care products significantly improve the health and wellbeing of patients.
- Industry Biotechnology Research
- Website https://solascure.com/
- LinkedIn https://www.linkedin.com/company/solascure/
Related People
Sam BakriFounder
United Kingdom -
Cambridge, England
Experienced executive and entrepreneur in life sciences, founded and exited life sciences companies in biopharmaceutical and medical devices.
Avtal | $24,000,000 | (Mar 20, 2026)
games2gether | $5,202,945 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Ezra AI Labs | $3,200,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Health Universe | $6,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)